Novo Nordisk

Pfizer CEO plans for soaring consumer market for obesity drugs akin to Viagra - SAN FRANCISCO, Jan 12 (Reuters) - Pfizer is preparing for a consumer market for obesity drugs on par with the booming business it saw after it launched erectile dysfunction drug Viagra in 1998, CEO Albert Bourla said on Monday. Bourla said
Canadian pharmacy platform to offer India-sourced Ozempic to US patients - By Siddhi Mahatole Jan 7 (Reuters) - Online pharmacy platform SaveRxCanada.to said on Wednesday it has begun offering Novo Nordisk's blockbuster diabetes drug, Ozempic, sourced from India to U.S.
Wegovy weight loss pill now available: How to get it and the cost - The oral medication serves as an alternative to the injectable version.
Exclusive-Novo Nordisk's US public affairs head leaves company, memo shows - LONDON/SAN FRANCISCO, Jan 5 (Reuters) - Danish obesity drugmaker Novo Nordisk's head of public affairs in the U. has left the company, according to an internal memo seen by Reuters, at a time when the firm ‌is battling to revive its fortun
Novo Nordisk to sell Wegovy pill to US self-pay patients starting at $149 per month - COPENHAGEN, Jan 5 () - Denmark's Novo Nordisk will offer its 1.5 and 4 milligram Wegovy weightloss pills ‌at $149 per month to self-paying patients in ‌the United States from January 5, it said on Monday.
FDA Approves Oral Version of Wegovy, First GLP-1 Pill Approved Specifically for Weight Management - The pill is expected to be available starting in January 2026.
Should You Invest in Ozempic Maker Novo Nordisk in 2026? - The pharmaceutical giant's stock has tumbled over the past year and a half, but it could be poised to storm back.
Prediction: 1 Healthcare Giant Set to Soar in 2026 - Novo Nordisk has struggled this past year, but its beaten-down valuation has made it a bargain buy today.